Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Read
E VistaGen Is Prepared For 2021 Fueled By Recent Analyst Upgrades And Large Institutional Buyers
VistaGen Therapeutics Announces Positive Meeting With FDA Regarding Pivotal Phase 3 Study Of PH94B For Acute Treatment Of Anxiety In Patients With Social Anxiety Disorder
Article By:
TalkMarkets Newswire
Thursday, July 23, 2020 9:00 AM EDT
VistaGen and the FDA reached consensus on key aspects of a unique initial pivotal Phase 3 clinical trial of PH94B involving a single-event, laboratory-simulated public speaking challenge in adult patients with SAD.
Week In Review: VistaGen Out-Licenses China/Asia Rights For Novel Anxiety Drug To EverInsight In $177 Million Deal
Article By:
ChinaBio® Today
Saturday, June 27, 2020 2:00 PM EDT
VistaGen of South San Francisco out-licensed China/Southeast Asia rights for a novel anxiety treatment to EverInsight Therapeutics, a China in-licensing company, in a $177 million agreement.
VistaGen Therapeutics And EverInsight Therapeutics Enter Strategic Collaboration To Develop And Commercialize PH94B For Anxiety Disorders In Greater China, South Korea And Southeast Asia
Article By:
TalkMarkets Newswire
Thursday, June 25, 2020 8:03 AM EDT
The collaboration is intended to support Phase 3 development and commercialization of PH94B in key Asian markets. The agreement includes a $5 million upfront payment and development and commercial milestones up to $172 million.
E VistaGen Therapeutics: Interesting Prospects
Article By:
Terry Chrisomalis
Tuesday, October 3, 2017 10:54 AM EDT
VistaGen's drug AV-101 has breakthrough potential for treatment of depression and other indications.
Rotation Opportunity As Three Top Psychedelic Stocks Explode
Great article TalkMarkets $MMEDF has been a BANGER $VTGN
is Kim Jong gonna make everyone take PH10??!!!!
VistaGen Therapeutics: Interesting Prospects
Thanks Terry! Will take a closer look at $VTGN.
VistaGen Therapeutics: Interesting Prospects
Your argument for acquisition sounds convincing, but I wonder if there have been any such overtures. Know if that's the case? Which companies would be the most likely to target #Vistagen? $VTGN.
VistaGen Therapeutics: Interesting Prospects
Looks promising. Sounds like $VTGN should be getting more love from investors.
VistaGen Therapeutics: Interesting Prospects
Definitely sounds like some interesting prospects indeed! $VTGN